James B. Leverenz

Also affiliated with Lou Ruvo Brain Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 51 papers. Top paper: “Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups”.

Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups

Brain(2021)10.1093/brain/awab402

N/A

1.4DataRank · unranked

66 citations

Zalak Shah, Ruth Chia, Sandra E. Black, Ziv Gan‐Or, Julia Keith +81 more

Research criteria for the diagnosis of prodromal dementia with Lewy bodies

Neurology(2020)10.1212/wnl.0000000000009323

N/A

0.992DataRank · unranked

745 citations

Tanis J. Ferman, Alan Thomas, Frédéric Blanc, Bradley F. Boeve, Hiroshige Fujishiro +26 more

Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials

Alzheimer s Research & Therapy(2020)10.1186/s13195-020-00703-5

N/A

0DataRank · unranked

69 citations

Leah K. Forsberg, Bradley F. Boeve, Melissa J. Armstrong, David J. Irwin, Tanis J. Ferman +15 more

Correlation between brain volume and retinal photoreceptor outer segment volume in normal aging and neurodegenerative diseases

PLoS ONE(2020)10.1371/journal.pone.0237078

N/A

0DataRank · unranked

32 citations

Jagan A. Pillai, Robert Bermel, Stephen E. Jones, Hubert H. Fernandez, James B. Leverenz +3 more

Inflammatory pathway analytes predicting rapid cognitive decline in MCI stage of Alzheimer’s disease

Annals of Clinical and Translational Neurology(2020)10.1002/acn3.51109

N/A

0DataRank · unranked

31 citations

James Bena, Gürkan Bebek, Lynn M. Bekris, Aaron Bonner‐Jackson, Lei Kou +9 more

A novel Alzheimer disease locus located near the gene encoding tau protein

UNC Libraries(2020)10.17615/7php-8b80

N/A

0DataRank · unranked

6 citations

Thomas Bird, DeStefano, Hanon, Tárraga, Allan I. Levey +95 more

Multimodal single-cell/nucleus RNA-sequencing data analysis uncovers molecular networks between disease-associated microglia and astrocytes with implications for drug repurposing in Alzheimer’s disease

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.23.310466

N/A

0DataRank · unranked

13 citations

Pengyue Zhang, Yin Huang, Lynn M. Bekris, Justin D. Lathia, Chien‐Wei Chiang +6 more

AlzGPS: A Genome-wide Positioning Systems Platform to Catalyze Multi-omics for Alzheimer’s Therapeutic Discovery

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.17.302612

N/A

0DataRank · unranked

0 citations

Jiansong Fang, Lynn M. Bekris, Young Heon Kim, Andrew A. Pieper, James B. Leverenz +3 more

Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid‐life: A randomized trial

Alzheimer s & Dementia(2021)10.1002/alz.12421

N/A

0DataRank · unranked

163 citations

Ashley H. Sanderlin, Laura D. Baker, Youngkyoo Jung, Samuel N. Lockhart, Derek Kellar +7 more

AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer’s drug discovery

Alzheimer s Research & Therapy(2021)10.1186/s13195-020-00760-w

N/A

0DataRank · unranked

88 citations

Jiansong Fang, Lynn M. Bekris, Young Heon Kim, Andrew A. Pieper, James B. Leverenz +3 more

TNFRSF1B Gene Variants and Related Soluble TNFR2 Levels Impact Resilience in Alzheimer's Disease

Frontiers in Aging Neuroscience(2021)10.3389/fnagi.2021.638922

N/A

0DataRank · unranked

33 citations

Gürkan Bebek, Maria Khrestian, James Bena, Cornelia C. Bergmann, William S. Bush +3 more

Dementia with Lewy bodies research consortia: A global perspective from the ISTAART Lewy Body Dementias Professional Interest Area working group

Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring(2021)10.1002/dad2.12235

N/A

0DataRank · unranked

26 citations

Joseph Kane, Agustín Ibáñez, Simon J.G. Lewis, Richard Camicioli, Huali Wang +13 more

Impact of APOE ε4 genotype on initial cognitive symptoms differs for Alzheimer’s and Lewy body neuropathology

Alzheimer s Research & Therapy(2021)10.1186/s13195-021-00771-1

N/A

0DataRank · unranked

23 citations

James Bena, Aaron Bonner‐Jackson, James B. Leverenz, Jagan A. Pillai

Lewy Body Dementia Association’s Industry Advisory Council: proceedings of the second annual meeting

Alzheimer s Research & Therapy(2021)10.1186/s13195-021-00868-7

N/A

0DataRank · unranked

1 citations

Bradley F. Boeve, Melissa J. Armstrong, Doug Galasko, James E. Galvin, David J. Irwin +14 more

Multimodal single-cell/nucleus RNA sequencing data analysis uncovers molecular networks between disease-associated microglia and astrocytes with implications for drug repurposing in Alzheimer's disease

Genome Research(2021)10.1101/gr.272484.120

N/A

0DataRank · unranked

82 citations

Pengyue Zhang, Yin Huang, Yadi Zhou, Yuan Hou, Lynn M. Bekris +8 more

Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium

Preprints.org(2021)10.20944/preprints202109.0133.v1

N/A

0DataRank · unranked

8 citations

Moriah R. Arnold, Thomas G. Beach, Christopher H. Gibbons, Anumantha G. Kanthasamy, Russell M. Lebovitz +40 more

LATE-NC staging in routine neuropathologic diagnosis: an update

Acta Neuropathologica(2022)10.1007/s00401-022-02524-2

N/A

0DataRank · unranked

178 citations

Edward B. Lee, Matthew D. Cykowski, Irina Alafuzoff, Konstantinos Arfanakis, Johannes Attems +45 more

Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease

Alzheimer s Research & Therapy(2022)10.1186/s13195-021-00951-z

N/A

0DataRank · unranked

121 citations

Pengyue Zhang, Quan Wang, Chien‐Wei Chiang, Yadi Zhou, Yuan Hou +11 more

Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer’s disease

Cell Reports(2022)10.1016/j.celrep.2022.111717

N/A

0DataRank · unranked

106 citations

Chengsheng Mao, Yuan Hou, Yuan Luo, Jessica Binder, Yadi Zhou +12 more

Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design

Alzheimer s & Dementia(2022)10.1002/alz.12814

N/A

0DataRank · unranked

97 citations

Carla Abdelnour, Rimona S. Weil, Daniel Ferreira, Federico Rodríguez‐Porcel, Andrea Pilotto +15 more

Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium

Frontiers in Neurology(2022)10.3389/fneur.2021.805135

N/A

0DataRank · unranked

32 citations

Moriah R. Arnold, Thomas G. Beach, Christopher H. Gibbons, Anumantha G. Kanthasamy, Russell M. Lebovitz +40 more

Population‐based discovery and Mendelian randomization analysis identify telmisartan as a candidate medicine for Alzheimer's disease in African Americans

Alzheimer s & Dementia(2022)10.1002/alz.12819

N/A

0DataRank · unranked

26 citations

Yuan Hou, Wanzhu Tu, Noll L. Campbell, Andrew A. Pieper, James B. Leverenz +4 more

Association of Variation in Behavioral Symptoms With Initial Cognitive Phenotype in Adults With Dementia Confirmed by Neuropathology

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.0729

N/A

0DataRank · unranked

25 citations

James Bena, Kasia Gustaw Rothenberg, Bryce Boron, James B. Leverenz, Jagan A. Pillai

Peripheral sTREM2-Related Inflammatory Activity Alterations in Early-Stage Alzheimer’s Disease

The Journal of Immunology(2022)10.4049/jimmunol.2100771

N/A

0DataRank · unranked

18 citations

Maria Khrestian, Elizabeth D. Tuason, Yvonne Shao, Jagan A. Pillai, Stephen M. Rao +8 more

Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer’s disease

Alzheimer s Research & Therapy(2023)10.1186/s13195-023-01203-y

N/A

0DataRank · unranked

70 citations

James Bena, Lynn M. Bekris, Nandan Kodur, Takhar Kasumov, James B. Leverenz +3 more

Microglial immunometabolism endophenotypes contribute to sex difference in Alzheimer's disease

Alzheimer s & Dementia(2023)10.1002/alz.13546

N/A

0DataRank · unranked

22 citations

Jessica Caldwell, Justin D. Lathia, James B. Leverenz, Andrew A. Pieper, Jeffrey L. Cummings +2 more

ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium

Alzheimer s & Dementia(2023)10.1002/alz.13398

N/A

0DataRank · unranked

21 citations

Maria Khrestian, Shane Formica, Elizabeth D. Tuason, Jagan A. Pillai, Stephen M. Rao +19 more

In vivo cortical diffusion imaging relates to Alzheimer’s disease neuropathology

Alzheimer s Research & Therapy(2023)10.1186/s13195-023-01309-3

N/A

0DataRank · unranked

16 citations

Gerard R. Ridgway, Michele Valotti, Ian Hardingham, Steven A. Chance, James B. Brewer +39 more

Listening session with the US Food and Drug Administration, Lewy Body Dementia Association, and an expert panel

Alzheimer s & Dementia Translational Research & Clinical Interventions(2023)10.1002/trc2.12375

N/A

0DataRank · unranked

14 citations

Angela Taylor, Douglas Galasko, James E. Galvin, Jennifer G. Goldman, James B. Leverenz +5 more

Initial non‐amnestic symptoms relate to faster rate of functional and cognitive decline compared to amnestic symptoms in neuropathologically confirmed dementias

Alzheimer s & Dementia(2023)10.1002/alz.12922

N/A

0DataRank · unranked

10 citations

James Bena, Emily F Maly, James B. Leverenz, Jagan A. Pillai

Association of cardiovascular disease management drugs with Lewy body dementia: a case–control study

Brain Communications(2023)10.1093/braincomms/fcad346

N/A

0DataRank · unranked

6 citations

Brian Moroz, Sara Sáez-Atiénzar, Ruth Chia, Elizabeth K. Cahoon, Clifton L. Dalgard +93 more

Lewy body dementia: Overcoming barriers and identifying solutions

Alzheimer s & Dementia(2024)10.1002/alz.13674

N/A

0DataRank · unranked

22 citations

Wendi Backler, Ece Bayram, Leah Bloom, Bradley F. Boeve, Jang‐Ho Cha +28 more

Within‐network changes in strength of the default mode network relate to Alzheimer’s Disease biomarkers in APOE e4 carriers

Alzheimer s & Dementia(2023)10.1002/alz.078477

N/A

0DataRank · unranked

0 citations

Sally Durgerian, Mark J. Lowe, Frank DiFilippo, Lynn M. Bekris, James B. Leverenz +2 more

Long-Term Dementia Risk in Parkinson Disease

Neurology(2024)10.1212/wnl.0000000000209699

N/A

0DataRank · unranked

76 citations

Caroline Gochanour, Chelsea Caspell‐Garcia, Roseanne D. Dobkin, Dag Aarsland, Roy N. Alcalay +88 more

Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer’s disease

Cell Reports Medicine(2024)10.1016/j.xcrm.2023.101379

N/A

0DataRank · unranked

57 citations

Fei Wang, Jian Tang, Yadi Zhou, Zhimin Fu, Pengyue Zhang +8 more

Association of CSF α-Synuclein Seeding Amplification Assay Results With Clinical Features of Possible and Probable Dementia With Lewy Bodies

Neurology(2024)10.1212/wnl.0000000000209656

N/A

0DataRank · unranked

43 citations

Karen MacLeod, John S. Middleton, Andrea Bozoki, James E. Galvin, David J. Irwin +16 more

Investigation of the genetic aetiology of Lewy body diseases with and without dementia

Brain Communications(2024)10.1093/braincomms/fcae190

N/A

0DataRank · unranked

12 citations

Raquel Real, Alejandro Martínez-Carrasco, Ruth Chia, Michael Lawton, Maryam Shoai +93 more

Single‐microglia transcriptomic transition network‐based prediction and real‐world patient data validation identifies ketorolac as a repurposable drug for Alzheimer's disease

Alzheimer s & Dementia(2024)10.1002/alz.14373

N/A

0DataRank · unranked

13 citations

Wenqiang Song, Zhenxing Xu, Michael M. Danziger, Ehud Karavani, Chengxi Zang +16 more

Multi-shell diffusion MRI of the fornix as a biomarker for cognition in Alzheimer's disease

Magnetic Resonance Imaging(2024)10.1016/j.mri.2024.03.030

N/A

0DataRank · unranked

6 citations

Katherine Koenig, Alan J. Lerner, Brian S. Appleby, Paula Ogrocki, Jagan A. Pillai +4 more

Lewy body pathology modifies risk factors for cerebral amyloid angiopathy when comorbid with Alzheimer's disease pathology

Alzheimer s & Dementia(2024)10.1002/alz.13704

N/A

0DataRank · unranked

8 citations

James Bena, Babak Tousi, Kasia Gustaw Rothenberg, C. Dirk Keene, James B. Leverenz +1 more

Single-nucleus multiome analysis of human cerebellum in Alzheimer’s disease-related dementia

Research Square(2024)10.21203/rs.3.rs-4871032/v1

N/A

0DataRank · unranked

4 citations

Yayan Feng, Margaret E. Flanagan, Borna Bonakdarpour, Pouya Jamshidi, Rudolph J. Castellani +12 more

A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson’s disease

Research Square(2024)10.21203/rs.3.rs-4869009/v1

N/A

0DataRank · unranked

0 citations

Lijun Dou, Zhigang Xu, Jielin Xu, Chang Su, Andrew A. Pieper +5 more

Real‐world observations of GLP‐1 receptor agonists and SGLT‐2 inhibitors as potential treatments for Alzheimer's disease

Alzheimer s & Dementia(2025)10.1002/alz.70639

N/A

0DataRank · unranked

16 citations

Chengsheng Mao, Anna Sun, Yuedi Yang, Yuan Hou, Zhimin Fu +7 more

A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson’s disease

npj Parkinson s Disease(2025)10.1038/s41531-025-00870-y

N/A

0DataRank · unranked

10 citations

Zhenxing Xu, Jielin Xu, Chengxi Zang, Chang Su, Andrew A. Pieper +6 more

Human herpesvirus‐associated transposable element activation in human aging brains with Alzheimer's disease

Alzheimer s & Dementia(2025)10.1002/alz.14595

N/A

0DataRank · unranked

13 citations

Shuqin Cao, Yi Shi, Anna Sun, Margaret E. Flanagan, James B. Leverenz +7 more

Recommended approaches to sharing individual research results in Alzheimer's disease research: A multidisciplinary expert Delphi consensus

Journal of Alzheimer s Disease(2025)10.1177/13872877251379076

N/A

0DataRank · unranked

3 citations

Megan Zelinsky, Paul J. Ford, James B. Leverenz, Jagan A. Pillai, Justin B. Miller +35 more

Protein co-aggregates of dense core amyloid plaques and CSF differ in rapidly progressive Alzheimer’s disease and slower sporadic Alzheimer’s disease

Alzheimer s Research & Therapy(2025)10.1186/s13195-025-01767-x

N/A

0DataRank · unranked

3 citations

Masaru Miyagi, Xinglong Wang, Brian S. Appleby, James B. Leverenz, Jagan A. Pillai +1 more

Non‐amnestic initial symptoms may be less prevalent in African American than White participants with Alzheimer's and mixed Lewy body and Alzheimer's pathology

Alzheimer s & Dementia(2025)10.1002/alz.70360

N/A

0DataRank · unranked

1 citations

Andrew X. Zhu, James B. Leverenz, Jagan A. Pillai, Quintasha Beamon

Combining genetics with real-world patient data enables ancestry-specific target identification and drug discovery in Alzheimer’s disease

Research Square(2025)10.21203/rs.3.rs-5716817/v1

N/A

0DataRank · unranked

3 citations

Yuan Hou, Pengyue Zhang, Yi‐Chen Li, Noah Lorincz‐Comi, Fan Fan +27 more

Poly(ADP-ribose) Polymerase 1 Deficiency Attenuates Amyloid Pathology, Neurodegeneration, and Cognitive Decline in a Familial Alzheimer’s Disease Model

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.06.674313

N/A

0DataRank · unranked

3 citations

Manisha Kumari, Trupti Tripathi, Rizwan Hasan Khan, Justin Wang, Lauren Guttman +14 more

Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing

Medicinal Research Reviews(2020)10.1002/med.21709

N/A

0DataRank · unranked

96 citations

Andrew A. Pieper, Ruth Nussinov, Garam Lee, Lynn M. Bekris, James B. Leverenz +3 more